RNF19A is a ring between ring finger (RBR) E3 ubiquitin ligase that functions primarily in protein ubiquitination and degradation pathways. The protein accepts ubiquitin from E2 conjugating enzymes UBE2L3 and UBE2L6, then transfers it to target substrates for proteasomal degradation 1. RNF19A demonstrates context-dependent roles in cancer, acting as a tumor suppressor in bladder cancer by ubiquitinating and degrading ILK, thereby inactivating the AKT/mTOR signaling pathway 2, while functioning as an oncogene in gastric cancer by degrading MST1 and disrupting the Hippo/YAP pathway 3. In DNA repair mechanisms, RNF19A inhibits homologous recombination by ubiquitinating BARD1, leading to dissociation of the BRCA1-BARD1 complex and enhanced sensitivity to PARP inhibitors 4. The protein also plays crucial roles in immune regulation, suppressing antiviral responses by degrading TBK1 5 and inhibiting type I interferon release through cGAS ubiquitination 6. During spermatogenesis, RNF19A localizes to acrosomal membranes and head-tail coupling apparatus, suggesting involvement in sperm development 7. Additionally, RNF19A contributes to drug resistance in rheumatoid arthritis by activating MAPK signaling through MKP-1 degradation 8.